The pathogenetic role of autoantibodies in systemic sclerosis (SSc) remains unclear, but
these autoantibodies have been established as strong predictors of disease outcome and the …

Objective To assess survival and incidence of organ‐based complications in a large single‐center
cohort of unselected systemic sclerosis (SSc) patients, and to explore predictors of …

Background: Systemic sclerosis (SSc) has high mortality and morbidity. Current management
focuses on early detection and treatment of organ-based manifestations. Aim: To …

… strategies for systemic sclerosis / SI Nihtyanova et al. … Current management strategies for
systemic sclerosis / SI Nihtyanova et al. … strategies for systemic sclerosis / SI Nihtyanova et al. …

Objectives . We have assessed indications, duration and tolerability of treatment with
mycophenolate mofetil (MMF) in patients with diffuse cutaneous systemic sclerosis (dcSSc), and …

Background: Vascular damage is a key pathological process in systemic sclerosis (SSc)
and accounts for significant disease-related morbidity. To determine the clinical burden of …

Objective To describe the associations between autoantibodies, clinical presentation, and
outcomes among patients with systemic sclerosis ( SS c) in order to develop a novel SS c …

Objective. IVIG is known to confer significant benefit in rheumatologic conditions, including
inflammatory myopathy. This study aimed to assess the efficacy of IVIG across different …

Objective Pulmonary arterial hypertension (PAH) is a severe complication of connective
tissue diseases (CTDs). This study aimed to investigate the clinical and hemodynamic …

Raynaud's phenomenon often precedes the diagnosis of systemic sclerosis and is the first
symptom of the disease in many cases. Antinuclear antibody positivity can assist in the early …